Literature DB >> 19562528

Epidemiology of atrial fibrillation.

D Conen1, S Osswald, C M Albert.   

Abstract

Atrial fibrillation is the most common sustained cardiac arrhythmia in the general population. Unfortunately, current treatment strategies aiming at the elimination of atrial fibrillation have limited long term success rates and significant risks. In this context, recent publications have provided many insights on potentially treatable risk factors for the occurrence of atrial fibrillation, such as alcohol, blood pressure, obesity, inflammation and nutritional factors. In this review, we summarise the current evidence on these risk factors and indicate areas in need of further investigation. The current evidence shows that blood pressure, hypertension and obesity seem to play a key role in the pathogenesis of atrial fibrillation. Preliminary evidence also suggests that inflammation is an important mediator of these associations. Knowledge of these interrelationships may eventually help to develop new treatment strategies and decrease the burden of atrial fibrillation in the general population.

Entities:  

Mesh:

Year:  2009        PMID: 19562528     DOI: smw-12500

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  13 in total

1.  Patient selection for ambulatory cardiac monitoring in the Indian healthcare environment.

Authors:  Maneesh Shrivastav; Rajendra Shrivastav; Jitendra Makkar; Mauro Biffi
Journal:  Heart Asia       Date:  2013-01-27

2.  Caffeine consumption and incident atrial fibrillation in women.

Authors:  David Conen; Stephanie E Chiuve; Brendan M Everett; Shumin M Zhang; Julie E Buring; Christine M Albert
Journal:  Am J Clin Nutr       Date:  2010-06-23       Impact factor: 7.045

3.  The burden of atrial fibrillation in the Netherlands.

Authors:  H E Heemstra; R Nieuwlaat; M Meijboom; H J Crijns
Journal:  Neth Heart J       Date:  2011-09       Impact factor: 2.380

4.  Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study.

Authors:  Samuel Adamsson Eryd; J Gustav Smith; Olle Melander; Bo Hedblad; Gunnar Engström
Journal:  Eur J Epidemiol       Date:  2011-03-19       Impact factor: 8.082

5.  R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation.

Authors:  Daniel C Bartos; Sabine Duchatelet; Don E Burgess; Didier Klug; Isabelle Denjoy; Rachel Peat; Jean-Marc Lupoglazoff; Véronique Fressart; Myriam Berthet; Michael J Ackerman; Craig T January; Pascale Guicheney; Brian P Delisle
Journal:  Heart Rhythm       Date:  2010-09-17       Impact factor: 6.343

Review 6.  Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis.

Authors:  Andriy V Samokhvalov; Hyacinth M Irving; Jürgen Rehm
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2010-12

7.  The ever-shrinking world of cardiac ion channel remodeling: the role of microRNAs in heart disease.

Authors:  Heather S Duffy
Journal:  Heart Rhythm       Date:  2009-09-18       Impact factor: 6.343

Review 8.  Update on anti-coagulation in atrial fibrillation.

Authors:  J Kreuzer
Journal:  QJM       Date:  2011-08-03

9.  Predictors of de novo atrial fibrillation in a non-cardiac intensive care unit.

Authors:  João Bicho Augusto; Ana Fernandes; Paulo Telles de Freitas; Victor Gil; Carlos Morais
Journal:  Rev Bras Ter Intensiva       Date:  2018 Apr-Jun

10.  Drug therapy in atrial fibrillation management: where do we stand in 2010?

Authors:  Gholamreza Davoodi; Mehdi Montazeri
Journal:  J Tehran Heart Cent       Date:  2010-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.